Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Spray vs Spray Plus Viscous Solution for Endoscopy
NCT06185933Enrolling by invitation
- Sponsor
- Sawanpracharak Hospital
- Start
- Feb 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of lidocaine 10% oropharyngeal spray (2 arms), sponsored by Sawanpracharak Hospital. Primary endpoint: Procedural pain (VAS). Started Feb 2024; status: enrolling by invitation.
02
Drugs
lidocaine 10% oropharyngeal spray
Beyond the preview
Go deeper on NCT06185933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06185933.